Gene therapy and Bio marker for Diabetes

Biomarkers are useful tools for research into type 1 diabetes (T1D) for a number of purposes, including elucidation of disease pathogenesis, risk prediction, and therapeutic monitoring. Susceptibility genes and islet autoantibodies are currently the most useful biomarkers for T1D risk prediction, progress, opportunities, challenges, and future directions in the development of T1D biomarkers.

 

    Related Conference of Gene therapy and Bio marker for Diabetes

    November 11-12, 2019

    Annual Congress on Diabetes, Metabolism and Obesity

    Sydney, Australia
    December 04-05, 2019

    3rd Annual Congress on Diabetes and Its Complications

    Tokyo, Japan
    December 9,10,2019

    International Congress and Expo on Diabetic Care

    Bangkok,Thailand
    December 12-13, 2019

    Annual Congress on Diabetes and Endocrinology

    Dubai, UAE
    January 27-28, 2020

    Global Summit On Diabetes & Endocrinology

    Bangkok, Thailand
    March 25-26, 2020

    29th World Diabetes & Heart Congress

    | Radisson Narita | Tokyo, Japan
    April 17-18, 2020

    3rd Global Meeting on Diabetes and Endocrinology

    Kualalumpur, Malaysia
    June 15-16, 2020

    29thEuropean Diabetes Congress

    | Barcelona, Spain
    August 17-18, 2020

    16th World Congress on Endocrinology & Diabetes

    | Copenhagen, Denmark
    Sept 22-23, 2020

    2nd Asia Pacific Endocrinology Congress

    | Singapore
    October 30-31, 2020

    Annual Summit on Metabolomics

    Vancouver, Canada
    November 16-17, 2020

    2nd Asia Pacific Diabetes and Endocrinology Congress

    Brisbane, Australia
    June 14-15, 2021

    diabetic 2021

    Abu Dhabi, UAE

    Gene therapy and Bio marker for Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in